Venderbos, Lionne D. F.
Roobol, Monique J.
Bangma, Chris H.
van den Bergh, Roderick C. N.
Bokhorst, Leonard P.
Nieboer, Daan
Godtman, Rebecka
Hugosson, Jonas
van der Kwast, Theodorus
Steyerberg, Ewout W.
Funding for this research was provided by:
Europe Against Cancer
the fifth and sixth framework program of the European Union
unconditional grants from Beckman- Coulter-Hybritech Inc
ERSPC Rotterdam - Dutch Cancer Society, the Netherlands organization for health and research development, the Abe Bonnema foundation
ERSPC Sweden - Abbott Pharmaceuticals, Sweden, Af Jochnick’s foundation, Catarina and Sven Hagstroms family foundation, Gunvor and Ivan Svensson’s foundation, Johanniterorden, King Gustav V Jubilée Clinic Cancer Research Foundation, Sahlgrenska University Hospital, Schering Plough, Sweden, Swedish Cancer Society, Wallac Oy, Turku, Finland